Hjem › Rhabdomyosarkom › Washington
Rhabdomyosarkom kliniske forsøg i Washington
3 studier for Rhabdomyosarkom søger deltagere på steder i Washington.
Byer i Washington
Officiel studietekst (engelsk)
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
- Seattle Children's Hospital, Seattle
- Mary Bridge Children's Hospital and Health Center, Tacoma
RekruttererFase 3
Op til 50 år · Alle køn · Opdateret 25. aug. 2026 · NCT07466316VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
- Seattle Children's, Seattle
RekruttererFase 1/2
6 Months – 30 Years · Alle køn · Opdateret 2. jun. 2026 · NCT04796012Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
- Seattle Children's Hospital, Seattle
RekruttererFase 1
Alder 1 til 26 · Alle køn · Opdateret 17. feb. 2026 · NCT07148050Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.